Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients. [electronic resource]
Producer: 20130913Description: 213-27 p. digitalISSN:- 1479-6821
- Antineoplastic Agents -- pharmacology
- Apoptosis
- Biomarkers, Tumor
- Carcinoma, Ovarian Epithelial
- Cell Line, Tumor
- Cisplatin -- pharmacology
- Cytoskeletal Proteins
- Drug Resistance, Neoplasm
- Epigenomics
- Female
- Gene Silencing
- Humans
- Methylation
- Neoplasms, Glandular and Epithelial -- genetics
- Ovarian Neoplasms -- genetics
- Paclitaxel -- pharmacology
- Prognosis
- RNA, Small Interfering -- genetics
- Tumor Suppressor Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.